Pharaoh’s curse: Turning toxic fungus into anti-cancer compound
Penn-led researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a…
Browsing: Featured News
Institute enhances immunotherapy for difficult-to-treat brain tumours with gut microbiota
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells,…
AI-driven TIL quantification shows superior consistency and strong prognostic value in melanoma
A new study published in JAMA Network Open has found that artificial intelligence (AI)–assisted assessment…
New ctDNA blood test shows high accuracy for colorectal cancer screening in average-risk adults
A landmark multicentre diagnostic study published in JAMA has evaluated an investigational circulating tumour DNA…
Improving the efficiency of glioblastoma immunotherapy with gut microbiota
Immunotherapies that activate T cells to eliminate cancer cells have shown limited efficacy as standalone…
Terahertz polarimetry detects microscopic tissue changes linked to cancer and burns
Recent advances in electronics and optics have opened new possibilities for terahertz (THz) waves—an invisible…
ASCO 2025: Vepdegestrant could extend progression-free survival for some people with ESR1-mutated advanced breast cancer
Results from VERITAC-2, the first global phase 3 clinical trial of a PROTAC, a targeted…
ASCO 2025: Pro-inflammatory diets associated with worse outcomes for stage III colon cancer
Results from a large, prospective cohort study show that eating a less inflammatory diet may…
ASCO 2025: Zanidatamab plus chemotherapy shows strong first-line efficacy in HER2-positive gastro-oesophageal adenocarcinoma
A phase 2 trial reports high response rates and durable outcomes in treatment-naive patients, presented…
Paediatric investigation study identifies immune drivers of medulloblastoma metastasis using explainable AI
Medulloblastoma, the most common malignant paediatric brain tumour, presents substantial clinical challenges due to its…